Total Payments
$3,698
2020 Payments
$243.24
Companies
24
Transactions
257
Medicare Patients
3,232
Medicare Billing
$248,255
Payment Breakdown by Category
Food & Beverage$3,698 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,698 | 257 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $671.83 | 44 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $565.42 | 42 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $406.06 | 26 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $370.62 | 20 | $0 (2020) |
| Gilead Sciences, Inc. | $257.61 | 30 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $209.43 | 15 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $146.79 | 13 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $145.38 | 8 | $0 (2019) |
| Amarin Pharma Inc. | $130.34 | 8 | $0 (2020) |
| PFIZER INC. | $100.79 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $243.24 | 14 | Kowa Pharmaceuticals America, Inc. ($42.75) |
| 2019 | $1,169 | 78 | Amgen Inc. ($208.95) |
| 2018 | $1,304 | 101 | Amgen Inc. ($195.45) |
| 2017 | $980.86 | 64 | Amgen Inc. ($247.32) |
All Payment Transactions
257 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: Cardiovascular | ||||||
| 05/20/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $20.50 | General |
| Category: Cardiovascular | ||||||
| 03/13/2020 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/11/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Cardiovascular | ||||||
| 03/09/2020 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/06/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/02/2020 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Pulmonology | ||||||
| 02/05/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2020 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/20/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular | ||||||
| 01/17/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/13/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardiology | ||||||
| 12/19/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.09 | General |
| Category: Cardiovascular | ||||||
| 12/18/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: Cardiology | ||||||
| 12/12/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Cardiology | ||||||
| 12/04/2019 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/25/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Cardiology | ||||||
| 11/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 16 | 1,158 | 1,219 | $209,320 | $74,081 |
| 2020 | 21 | 2,074 | 2,605 | $483,905 | $174,174 |
Total Patients
3,232
Total Services
3,824
Medicare Billing
$248,255
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 416 | 445 | $57,850 | $27,046 | 46.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 181 | 181 | $77,830 | $25,581 | 32.9% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 35 | 35 | $16,975 | $5,634 | 33.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 59 | $10,619 | $4,717 | 44.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 34 | 37 | $3,600 | $1,743 | 48.4% |
| 93320 | Doppler ultrasound study of heart blood flow, valves, and chambers | Office | 2021 | 35 | 35 | $4,690 | $1,359 | 29.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 141 | 141 | $9,870 | $1,273 | 12.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 30 | 31 | $2,170 | $1,070 | 49.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,475 | $952.31 | 38.5% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2021 | 31 | 34 | $3,060 | $910.26 | 29.7% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2021 | 49 | 60 | $4,200 | $880.91 | 21.0% |
| 93296 | Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days | Office | 2021 | 49 | 60 | $3,900 | $736.67 | 18.9% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 12 | 12 | $2,400 | $703.59 | 29.3% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Office | 2021 | 35 | 35 | $7,490 | $633.28 | 8.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 23 | 24 | $1,516 | $530.27 | 35.0% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2021 | 15 | 15 | $675.00 | $310.05 | 45.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 632 | 842 | $138,930 | $61,610 | 44.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 328 | 334 | $143,620 | $46,897 | 32.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2020 | 18 | 97 | $43,650 | $14,986 | 34.3% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2020 | 64 | 64 | $31,040 | $10,990 | 35.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 123 | 142 | $12,780 | $8,263 | 64.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 51 | 51 | $13,515 | $5,431 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 88 | 106 | $13,780 | $5,254 | 38.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 278 | 281 | $19,670 | $2,935 | 14.9% |
| 93320 | Doppler ultrasound study of heart blood flow, valves, and chambers | Office | 2020 | 64 | 64 | $8,576 | $2,625 | 30.6% |
About Dr. Jorge Martinez, MD
Dr. Jorge Martinez, MD is a Cardiovascular Disease healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902892714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jorge Martinez, MD has received a total of $3,698 in payments from pharmaceutical and medical device companies, with $243.24 received in 2020. These payments were reported across 257 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,698).
As a Medicare-enrolled provider, Martinez has provided services to 3,232 Medicare beneficiaries, totaling 3,824 services with total Medicare billing of $248,255. Data is available for 2 years (2020–2021), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Syracuse, NY
- Active Since 09/27/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1902892714
Products in Payments
- Corlanor (Drug) $596.23
- XARELTO (Drug) $565.42
- ENTRESTO (Drug) $406.06
- PRADAXA (Drug) $370.62
- ELIQUIS (Drug) $166.12
- Adempas (Drug) $145.38
- Vascepa (Drug) $130.34
- MULTAQ (Drug) $125.45
- OPSUMIT MACITENTAN (Drug) $109.01
- Livalo (Drug) $96.53
- BRILINTA (Drug) $86.42
- PRALUENT (Drug) $83.98
- Repatha (Biological) $75.60
- Veltassa (Drug) $62.91
- Impella (Device) $39.98
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $37.23
- TEGSEDI (Drug) $35.20
- CHANTIX (Drug) $34.44
- Evera (Device) $31.75
- BYSTOLIC (Drug) $30.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Syracuse
Saverio Barbera, Md, MD
Cardiovascular Disease — Payments: $41,547
Cardiovascular Disease $41,547
Dr. Kiran Devaraj, M.d, M.D
Cardiovascular Disease — Payments: $36,432
Cardiovascular Disease $36,432
Dr. Nikhil Joshi, M.d, M.D
Cardiovascular Disease — Payments: $28,775
Cardiovascular Disease $28,775
Dr. Ankur Kalra, Md, MD
Cardiovascular Disease — Payments: $26,848
Cardiovascular Disease $26,848
Dr. Tristan Petrie, Md, MD
Cardiovascular Disease — Payments: $18,178
Cardiovascular Disease $18,178
Michael Gabris, Md Facc, MD FACC
Cardiovascular Disease — Payments: $11,834
Cardiovascular Disease $11,834